association

Full identifier: http://purl.org/np/RARoqiY5zLrsQzO2p81HTkdifDz9vsat_Bg-ls6MBzirM#association

Assigned to 1 class:

Minted in Nanopublication

 RARoqiY5zL comment approve/disapprove edit as derived nanopublication create new with same template

This is the identifier for this whole nanopublication. http://purl.org/np/RARoqiY5zL... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-08-23T13:12:28.811+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RARoqiY5zL... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAhNHZw6Ur... RAhNHZw6Ur .
This is the identifier for this whole nanopublication. http://purl.org/np/RARoqiY5zL... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RARoqiY5zL... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .

References

Nanopublication Part Subject Predicate Object Published By Published On
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T11:12:28.811Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
"Risedronate Sodium is contraindicated in patients with the following conditions: Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia [ see Warnings and Precautions ( 5.1 ) Inability to stand or sit upright for at least 30 minutes [ see Dosage and Administration ( 2 ), Warnings and Precautions ( 5.1 ) Hypocalcemia [ see Warnings and Precautions ( 5.2 ) Known hypersensitivity to Risedronate Sodium or any of its excipients. Angioedema, generalized rash, bullous skin reactions, Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported [ see Adverse Reactions ( 6.2 ) Abnormalities of the esophagus which delay esophageal emptying such as stricture or achalasia ( 4 5.1 Inability to stand or sit upright for at least 30 minutes ( 4 5.1 Hypocalcemia ( 4 5.2 Known hypersensitivity to any component of this product ( 4 6.2"
Leoni Bücken
2021-08-23T11:12:28.811Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T11:12:28.811Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T11:12:28.811Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T11:12:28.811Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T11:12:28.811Z
links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion
association
Leoni Bücken
2021-08-23T11:12:28.811Z

Raw

TriG(txt), JSON-LD(txt), N-Quads(txt), XML(txt)